ATM and colorectal carcinoma: For instance, a selective ATM inhibitor was shown to enhance the sensitivity of CRC cell lines to irinotecan in vitro and confer drug sensitivity to CRC patient-derived xenografts that were resistant to irinotecan monotherapy [139].